This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $321,363 to Nucleusrx, Inc. to develop and test a virtual care platform and remote intervention tool for post-acute care heart failure patients transitioning from hospital to home. The key products and services to be delivered include:
-
A physical device consisting of a pill dispenser, blood pressure monitor, and weight scale, integrated with an interconnected software platform and mobile app to enable remote monitoring and management of heart failure patients after hospital discharge.
-
Clinical feasibility testing of the virtual care platform with heart failure patients over a 28-day period to assess medication compliance, patient/provider satisfaction, and usability.
-
Improvements to the software user interfaces and integration with the EPIC electronic health record system based on feedback from patients, caregivers, and providers.
The overarching goal is to reduce emergency hospital readmissions and improve guideline-directed medical therapy delivery for heart failure patients transitioning from the hospital to home setting. The award begins on September 1, 2024 and is expected to be completed by August 31, 2025.
Generated 1/28/25, 10:02 AM